BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Murry CE, Reinecke H, Pabon LM. Regeneration gaps: observations on stem cells and cardiac repair. J Am Coll Cardiol. 2006;47:1777-1785. [PMID: 16682301 DOI: 10.1016/j.jacc.2006.02.002] [Cited by in Crossref: 245] [Cited by in F6Publishing: 193] [Article Influence: 16.3] [Reference Citation Analysis]
Number Citing Articles
1 Menasché P. Skeletal Myoblasts as a Therapeutic Agent. Progress in Cardiovascular Diseases 2007;50:7-17. [DOI: 10.1016/j.pcad.2007.02.002] [Cited by in Crossref: 95] [Cited by in F6Publishing: 76] [Article Influence: 6.8] [Reference Citation Analysis]
2 Maltais S, Tremblay JP, Perrault LP, Ly HQ. The paracrine effect: pivotal mechanism in cell-based cardiac repair. J Cardiovasc Transl Res 2010;3:652-62. [PMID: 20559770 DOI: 10.1007/s12265-010-9198-2] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
3 Ravichandran R, Venugopal JR, Sundarrajan S, Mukherjee S, Ramakrishna S. Cardiogenic differentiation of mesenchymal stem cells on elastomeric poly (glycerol sebacate)/collagen core/shell fibers. World J Cardiol 2013;5:28-41. [PMID: 23539543 DOI: 10.4330/wjc.v5.i3.28] [Cited by in Crossref: 55] [Cited by in F6Publishing: 38] [Article Influence: 6.9] [Reference Citation Analysis]
4 Cho HJ, Lee N, Lee JY, Choi YJ, Ii M, Wecker A, Jeong JO, Curry C, Qin G, Yoon YS. Role of host tissues for sustained humoral effects after endothelial progenitor cell transplantation into the ischemic heart. J Exp Med 2007;204:3257-69. [PMID: 18070934 DOI: 10.1084/jem.20070166] [Cited by in Crossref: 208] [Cited by in F6Publishing: 184] [Article Influence: 14.9] [Reference Citation Analysis]
5 Ye Y, Bogaert J. Cell therapy in myocardial infarction: emphasis on the role of MRI. Eur Radiol 2008;18:548-69. [DOI: 10.1007/s00330-007-0777-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
6 Vogel R, Hussein EA, Mousa SA. Stem cells in the management of heart failure: what have we learned from clinical trials? Expert Rev Cardiovasc Ther 2015;13:75-83. [PMID: 25434419 DOI: 10.1586/14779072.2015.988142] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
7 Windecker S, Bax JJ, Myat A, Stone GW, Marber MS. Future treatment strategies in ST-segment elevation myocardial infarction. Lancet 2013;382:644-57. [PMID: 23953388 DOI: 10.1016/S0140-6736(13)61452-X] [Cited by in Crossref: 45] [Cited by in F6Publishing: 20] [Article Influence: 5.6] [Reference Citation Analysis]
8 Cutts J, Nikkhah M, Brafman DA. Biomaterial Approaches for Stem Cell-Based Myocardial Tissue Engineering. Biomark Insights 2015;10:77-90. [PMID: 26052226 DOI: 10.4137/BMI.S20313] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
9 Silvestri A, Boffito M, Sartori S, Ciardelli G. Biomimetic Materials and Scaffolds for Myocardial Tissue Regeneration: Materials and Scaffolds for Cardiac Regeneration. Macromol Biosci 2013;13:984-1019. [DOI: 10.1002/mabi.201200483] [Cited by in Crossref: 63] [Cited by in F6Publishing: 46] [Article Influence: 7.9] [Reference Citation Analysis]
10 Winter EM, Grauss RW, Hogers B, van Tuyn J, van der Geest R, Lie-Venema H, Steijn RV, Maas S, DeRuiter MC, deVries AA, Steendijk P, Doevendans PA, van der Laarse A, Poelmann RE, Schalij MJ, Atsma DE, Gittenberger-de Groot AC. Preservation of left ventricular function and attenuation of remodeling after transplantation of human epicardium-derived cells into the infarcted mouse heart. Circulation 2007;116:917-27. [PMID: 17684151 DOI: 10.1161/CIRCULATIONAHA.106.668178] [Cited by in Crossref: 111] [Cited by in F6Publishing: 56] [Article Influence: 7.9] [Reference Citation Analysis]
11 Almohammedi A, Kapetanaki SM, Wood BR, Raven EL, Storey NM, Hudson AJ. Spectroscopic analysis of myoglobin and cytochrome c dynamics in isolated cardiomyocytes during hypoxia and reoxygenation. J R Soc Interface 2015;12:20141339. [PMID: 25694541 DOI: 10.1098/rsif.2014.1339] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
12 Khait L, Birla RK. Cell-based cardiac pumps and tissue-engineered ventricles. Regenerative Medicine 2007;2:391-406. [DOI: 10.2217/17460751.2.4.391] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
13 Frantz S, Vallabhapurapu D, Tillmanns J, Brousos N, Wagner H, Henig K, Ertl G, Müller AM, Bauersachs J. Impact of different bone marrow cell preparations on left ventricular remodelling after experimental myocardial infarction. Eur J Heart Fail 2008;10:119-24. [PMID: 18279767 DOI: 10.1016/j.ejheart.2007.11.009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
14 Sreejit P, Verma RS. Natural ECM as biomaterial for scaffold based cardiac regeneration using adult bone marrow derived stem cells. Stem Cell Rev Rep 2013;9:158-71. [PMID: 23319217 DOI: 10.1007/s12015-013-9427-6] [Cited by in Crossref: 42] [Cited by in F6Publishing: 30] [Article Influence: 5.3] [Reference Citation Analysis]
15 Jara Avaca M, Gruh I. Bioengineered Cardiac Tissue Based on Human Stem Cells for Clinical Application. Adv Biochem Eng Biotechnol. 2018;163:117-146. [PMID: 29218360 DOI: 10.1007/10_2017_24] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
16 Schwedhelm I, Zdzieblo D, Appelt-Menzel A, Berger C, Schmitz T, Schuldt B, Franke A, Müller FJ, Pless O, Schwarz T, Wiedemann P, Walles H, Hansmann J. Automated real-time monitoring of human pluripotent stem cell aggregation in stirred tank reactors. Sci Rep 2019;9:12297. [PMID: 31444389 DOI: 10.1038/s41598-019-48814-w] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
17 Huang Q, Chen M, Liang S, Acha V, Liu D, Yuan F, Hawks CL, Hornsby PJ. Improving cell therapy--experiments using transplanted telomerase-immortalized cells in immunodeficient mice. Mech Ageing Dev 2007;128:25-30. [PMID: 17123586 DOI: 10.1016/j.mad.2006.11.006] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
18 Mauritz C, Martens A, Rojas SV, Schnick T, Rathert C, Schecker N, Menke S, Glage S, Zweigerdt R, Haverich A, Martin U, Kutschka I. Induced pluripotent stem cell (iPSC)-derived Flk-1 progenitor cells engraft, differentiate, and improve heart function in a mouse model of acute myocardial infarction. European Heart Journal 2011;32:2634-41. [DOI: 10.1093/eurheartj/ehr166] [Cited by in Crossref: 116] [Cited by in F6Publishing: 96] [Article Influence: 11.6] [Reference Citation Analysis]
19 Demaria AN, Ben-yehuda O, Feld GK, Ginsburg GS, Greenberg BH, Lew WY, Lima JA, Maisel AS, Narula J, Sahn DJ, Tsimikas S. Highlights of the Year in JACC2006. Journal of the American College of Cardiology 2007;49:509-27. [DOI: 10.1016/j.jacc.2006.12.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
20 Shah VK, Shalia KK. Stem Cell Therapy in Acute Myocardial Infarction: A Pot of Gold or Pandora's Box. Stem Cells Int 2011;2011:536758. [PMID: 21804827 DOI: 10.4061/2011/536758] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
21 Yeong W, Sudarmadji N, Yu H, Chua C, Leong K, Venkatraman S, Boey Y, Tan L. Porous polycaprolactone scaffold for cardiac tissue engineering fabricated by selective laser sintering. Acta Biomaterialia 2010;6:2028-34. [DOI: 10.1016/j.actbio.2009.12.033] [Cited by in Crossref: 231] [Cited by in F6Publishing: 140] [Article Influence: 21.0] [Reference Citation Analysis]
22 Godier-Furnémont AF, Martens TP, Koeckert MS, Wan L, Parks J, Arai K, Zhang G, Hudson B, Homma S, Vunjak-Novakovic G. Composite scaffold provides a cell delivery platform for cardiovascular repair. Proc Natl Acad Sci U S A 2011;108:7974-9. [PMID: 21508321 DOI: 10.1073/pnas.1104619108] [Cited by in Crossref: 192] [Cited by in F6Publishing: 148] [Article Influence: 19.2] [Reference Citation Analysis]
23 Deng C, Zhang P, Vulesevic B, Kuraitis D, Li F, Yang AF, Griffith M, Ruel M, Suuronen EJ. A collagen–chitosan hydrogel for endothelial differentiation and angiogenesis. Tissue Eng Part A 2010;16:3099-109. [PMID: 20586613 DOI: 10.1089/ten.tea.2009.0504] [Cited by in Crossref: 102] [Cited by in F6Publishing: 70] [Article Influence: 10.2] [Reference Citation Analysis]
24 Karantalis V, Balkan W, Schulman IH, Hatzistergos KE, Hare JM. Cell-based therapy for prevention and reversal of myocardial remodeling. Am J Physiol Heart Circ Physiol. 2012;303:H256-H270. [PMID: 22636682 DOI: 10.1152/ajpheart.00221.2012] [Cited by in Crossref: 63] [Cited by in F6Publishing: 46] [Article Influence: 7.0] [Reference Citation Analysis]
25 Angelini A, Castellani C, Tona F, Gambino A, Caforio AP, Feltrin G, Della Barbera M, Valente M, Gerosa G, Thiene G. Continuous engraftment and differentiation of male recipient Y-chromosome-positive cardiomyocytes in donor female human heart transplants. J Heart Lung Transplant. 2007;26:1110-1118. [PMID: 18022076 DOI: 10.1016/j.healun.2007.08.004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
26 Laflamme MA, Murry CE. Heart regeneration. Nature. 2011;473:326-335. [PMID: 21593865 DOI: 10.1038/nature10147] [Cited by in Crossref: 796] [Cited by in F6Publishing: 670] [Article Influence: 79.6] [Reference Citation Analysis]
27 Mathison M, Gersch RP, Nasser A, Lilo S, Korman M, Fourman M, Hackett N, Shroyer K, Yang J, Ma Y, Crystal RG, Rosengart TK. In vivo cardiac cellular reprogramming efficacy is enhanced by angiogenic preconditioning of the infarcted myocardium with vascular endothelial growth factor. J Am Heart Assoc 2012;1:e005652. [PMID: 23316332 DOI: 10.1161/JAHA.112.005652] [Cited by in Crossref: 83] [Cited by in F6Publishing: 49] [Article Influence: 9.2] [Reference Citation Analysis]
28 Sipido KR, Tedgui A, Kristensen SD, Pasterkamp G, Schunkert H, Wehling M, Steg PG, Eisert W, Rademakers F, Casadei B, Fuster V, Cerbai E, Hasenfuss G, Fernandez-Aviles F, Garcia-Dorado D, Vidal M, Hallen M, Dambrauskaite V. Identifying needs and opportunities for advancing translational research in cardiovascular disease. Cardiovasc Res 2009;83:425-35. [PMID: 19502281 DOI: 10.1093/cvr/cvp165] [Cited by in Crossref: 26] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
29 Simpson D, Liu H, Fan TH, Nerem R, Dudley SC. A tissue engineering approach to progenitor cell delivery results in significant cell engraftment and improved myocardial remodeling. Stem Cells. 2007;25:2350-2357. [PMID: 17525236 DOI: 10.1634/stemcells.2007-0132] [Cited by in Crossref: 152] [Cited by in F6Publishing: 124] [Article Influence: 10.9] [Reference Citation Analysis]
30 Hao M, Wang R, Wang W. Cell Therapies in Cardiomyopathy: Current Status of Clinical Trials. Anal Cell Pathol (Amst) 2017;2017:9404057. [PMID: 28194324 DOI: 10.1155/2017/9404057] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
31 Sicari BM, Londono R, Badylak SF. Strategies for skeletal muscle tissue engineering: seed vs. soil. J Mater Chem B 2015;3:7881-95. [PMID: 32262901 DOI: 10.1039/c5tb01714a] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
32 Gersh BJ, Simari RD, Behfar A, Terzic CM, Terzic A. Cardiac Cell Repair Therapy: A Clinical Perspective. Mayo Clinic Proceedings 2009;84:876-92. [DOI: 10.4065/84.10.876] [Cited by in Crossref: 110] [Cited by in F6Publishing: 44] [Article Influence: 9.2] [Reference Citation Analysis]
33 Li Y, Jiang X, Li L, Chen ZN, Gao G, Yao R, Sun W. 3D printing human induced pluripotent stem cells with novel hydroxypropyl chitin bioink: scalable expansion and uniform aggregation. Biofabrication 2018;10:044101. [PMID: 29952313 DOI: 10.1088/1758-5090/aacfc3] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 6.7] [Reference Citation Analysis]
34 Chimenti I, Forte E, Angelini F, Messina E, Giacomello A. Biochemistry and biology: heart-to-heart to investigate cardiac progenitor cells. Biochim Biophys Acta 2013;1830:2459-69. [PMID: 22921810 DOI: 10.1016/j.bbagen.2012.08.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
35 Kammili RK, Taylor DG, Xia J, Osuala K, Thompson K, Menick DR, Ebert SN. Generation of novel reporter stem cells and their application for molecular imaging of cardiac-differentiated stem cells in vivo. Stem Cells Dev. 2010;19:1437-1448. [PMID: 20109065 DOI: 10.1089/scd.2009.0308] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
36 Ailawadi S, Wang X, Gu H, Fan GC. Pathologic function and therapeutic potential of exosomes in cardiovascular disease. Biochim Biophys Acta. 2015;1852:1-11. [PMID: 25463630 DOI: 10.1016/j.bbadis.2014.10.008] [Cited by in Crossref: 139] [Cited by in F6Publishing: 131] [Article Influence: 19.9] [Reference Citation Analysis]
37 Blumenthal B, Golsong P, Poppe A, Heilmann C, Schlensak C, Beyersdorf F, Siepe M. Polyurethane Scaffolds Seeded With Genetically Engineered Skeletal Myoblasts: A Promising Tool to Regenerate Myocardial Function. Artificial Organs 2010;34:E46-54. [DOI: 10.1111/j.1525-1594.2009.00937.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
38 Smart N, Riley PR. The epicardium as a candidate for heart regeneration. Future Cardiol 2012;8:53-69. [PMID: 22185446 DOI: 10.2217/fca.11.87] [Cited by in Crossref: 38] [Cited by in F6Publishing: 26] [Article Influence: 4.2] [Reference Citation Analysis]
39 Schannwell CM, Ott G, Brehm M, Bartsch T, Strauer BE. Fünf Jahre autologe intrakoronare Stammzelltransplantation: Aktueller Stand und Perspektiven. Internist 2006;47:1087-92. [DOI: 10.1007/s00108-006-1697-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
40 Schnabel K, Wu CC, Kurth T, Weidinger G. Regeneration of cryoinjury induced necrotic heart lesions in zebrafish is associated with epicardial activation and cardiomyocyte proliferation. PLoS One 2011;6:e18503. [PMID: 21533269 DOI: 10.1371/journal.pone.0018503] [Cited by in Crossref: 177] [Cited by in F6Publishing: 154] [Article Influence: 17.7] [Reference Citation Analysis]
41 Germani A, Di Rocco G, Limana F, Martelli F, Capogrossi MC. Molecular mechanisms of cardiomyocyte regeneration and therapeutic outlook. Trends Mol Med 2007;13:125-33. [PMID: 17257896 DOI: 10.1016/j.molmed.2007.01.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
42 Kennedy-Lydon T, Rosenthal N. Cardiac regeneration: epicardial mediated repair. Proc Biol Sci 2015;282:20152147. [PMID: 26702046 DOI: 10.1098/rspb.2015.2147] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
43 Zhang H, Hou JF, Shen Y, Wang W, Wei YJ, Hu S. Low level laser irradiation precondition to create friendly milieu of infarcted myocardium and enhance early survival of transplanted bone marrow cells. J Cell Mol Med 2010;14:1975-87. [PMID: 19725921 DOI: 10.1111/j.1582-4934.2009.00886.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 2.9] [Reference Citation Analysis]
44 Jeż M, Martyniak A, Andrysiak K, Mucha O, Szade K, Kania A, Chrobok Ł, Palus-Chramiec K, Sanetra AM, Lewandowski MH, Pośpiech E, Stępniewski J, Dulak J. Role of Heme-Oxygenase-1 in Biology of Cardiomyocytes Derived from Human Induced Pluripotent Stem Cells. Cells 2021;10:522. [PMID: 33804563 DOI: 10.3390/cells10030522] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
45 Li Y, Li L, Chen Z, Gao G, Yao R, Sun W. Engineering-derived approaches for iPSC preparation, expansion, differentiation and applications. Biofabrication 2017;9:032001. [DOI: 10.1088/1758-5090/aa7e9a] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
46 Kwon YW, Yang HM, Cho HJ. Cell therapy for myocardial infarction. Int J Stem Cells 2010;3:8-15. [PMID: 24855535 DOI: 10.15283/ijsc.2010.3.1.8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
47 Jonker SS, Faber JJ, Anderson DF, Thornburg KL, Louey S, Giraud GD. Sequential growth of fetal sheep cardiac myocytes in response to simultaneous arterial and venous hypertension. Am J Physiol Regul Integr Comp Physiol 2007;292:R913-9. [PMID: 17023664 DOI: 10.1152/ajpregu.00484.2006] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 2.7] [Reference Citation Analysis]
48 Zimpfer D, Aharinejad S, Holfeld J, Thomas A, Dumfarth J, Rosenhek R, Czerny M, Schaden W, Gmeiner M, Wolner E, Grimm M. Direct epicardial shock wave therapy improves ventricular function and induces angiogenesis in ischemic heart failure. J Thorac Cardiovasc Surg 2009;137:963-70. [PMID: 19327525 DOI: 10.1016/j.jtcvs.2008.11.006] [Cited by in Crossref: 38] [Cited by in F6Publishing: 28] [Article Influence: 3.2] [Reference Citation Analysis]
49 Rosenberg M, Lutz M, Kuhl C, Will R, Eckstein V, Krebs J, Katus HA, Frey N. Coculture with hematopoietic stem cells protects cardiomyocytes against apoptosis via paracrine activation of AKT. J Transl Med. 2012;10:115. [DOI: 10.1186/1479-5876-10-115] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
50 Hartman ME, Dai DF, Laflamme MA. Human pluripotent stem cells: Prospects and challenges as a source of cardiomyocytes for in vitro modeling and cell-based cardiac repair. Adv Drug Deliv Rev 2016;96:3-17. [PMID: 25980938 DOI: 10.1016/j.addr.2015.05.004] [Cited by in Crossref: 86] [Cited by in F6Publishing: 62] [Article Influence: 14.3] [Reference Citation Analysis]
51 dos Santos L, Santos AA, Gonçalves GA, Krieger JE, Tucci PJ. Bone marrow cell therapy prevents infarct expansion and improves border zone remodeling after coronary occlusion in rats. Int J Cardiol 2010;145:34-9. [PMID: 19577315 DOI: 10.1016/j.ijcard.2009.06.008] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
52 Cho HJ, Lee HJ, Youn SW, Koh SJ, Won JY, Chung YJ, Cho HJ, Yoon CH, Lee SW, Lee EJ. Secondary sphere formation enhances the functionality of cardiac progenitor cells. Mol Ther. 2012;20:1750-1766. [PMID: 22713697 DOI: 10.1038/mt.2012.109] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
53 Zimmer A, Bagchi AK, Vinayak K, Bello-Klein A, Singal PK. Innate immune response in the pathogenesis of heart failure in survivors of myocardial infarction. Am J Physiol Heart Circ Physiol 2019;316:H435-45. [PMID: 30525893 DOI: 10.1152/ajpheart.00597.2018] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
54 Deutsch MA, Sturzu A, Wu SM. At a crossroad: cell therapy for cardiac repair. Circ Res 2013;112:884-90. [PMID: 23493304 DOI: 10.1161/CIRCRESAHA.112.275974] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
55 Jiang YH, Zhu Y, Chen S, Wang HL, Zhou Y, Tang FQ, Jian Z, Xiao YB. Re-enforcing hypoxia-induced polyploid cardiomyocytes enter cytokinesis through activation of β-catenin. Sci Rep 2019;9:17865. [PMID: 31780774 DOI: 10.1038/s41598-019-54334-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
56 Kim SH, Park G, Hyun H, Lee JH, Ashitate Y, Choi J, Hong GH, Owens EA, Henary M, Choi HS. Near-infrared lipophilic fluorophores for tracing tissue growth. Biomed Mater 2013;8:014110. [PMID: 23353894 DOI: 10.1088/1748-6041/8/1/014110] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
57 Hare JM, Chaparro SV. Cardiac regeneration and stem cell therapy. Curr Opin Organ Transplant 2008;13:536-42. [PMID: 19060539 DOI: 10.1097/MOT.0b013e32830fdfc4] [Cited by in Crossref: 52] [Cited by in F6Publishing: 26] [Article Influence: 4.3] [Reference Citation Analysis]
58 Feyen DAM, Gaetani R, Doevendans PA, Sluijter JPG. Stem cell-based therapy: Improving myocardial cell delivery. Adv Drug Deliv Rev 2016;106:104-15. [PMID: 27133386 DOI: 10.1016/j.addr.2016.04.023] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
59 Wu SM, Chien KR, Mummery C. Origins and fates of cardiovascular progenitor cells. Cell 2008;132:537-43. [PMID: 18295570 DOI: 10.1016/j.cell.2008.02.002] [Cited by in Crossref: 141] [Cited by in F6Publishing: 122] [Article Influence: 10.8] [Reference Citation Analysis]
60 Sheng CC, Zhou L, Hao J. Current stem cell delivery methods for myocardial repair. Biomed Res Int. 2013;2013:547902. [PMID: 23509740 DOI: 10.1155/2013/547902] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 3.9] [Reference Citation Analysis]
61 Chatterjee M, Gawaz M. Platelet-derived CXCL12 (SDF-1α): basic mechanisms and clinical implications. J Thromb Haemost. 2013;11:1954-1967. [PMID: 24024928 DOI: 10.1111/jth.12404] [Cited by in Crossref: 59] [Cited by in F6Publishing: 45] [Article Influence: 9.8] [Reference Citation Analysis]
62 Brown BN, Sicari BM, Badylak SF. Rethinking regenerative medicine: a macrophage-centered approach. Front Immunol 2014;5:510. [PMID: 25408693 DOI: 10.3389/fimmu.2014.00510] [Cited by in Crossref: 87] [Cited by in F6Publishing: 86] [Article Influence: 12.4] [Reference Citation Analysis]
63 Strauer BE, Brehm M, Schannwell CM. The therapeutic potential of stem cells in heart disease. Cell Prolif 2008;41 Suppl 1:126-45. [PMID: 18181953 DOI: 10.1111/j.1365-2184.2008.00480.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
64 Niebruegge S, Bauwens CL, Peerani R, Thavandiran N, Masse S, Sevaptisidis E, Nanthakumar K, Woodhouse K, Husain M, Kumacheva E. Generation of human embryonic stem cell-derived mesoderm and cardiac cells using size-specified aggregates in an oxygen-controlled bioreactor. Biotechnol Bioeng. 2009;102:493-507. [PMID: 18767184 DOI: 10.1002/bit.22065] [Cited by in Crossref: 161] [Cited by in F6Publishing: 131] [Article Influence: 13.4] [Reference Citation Analysis]
65 Jin G, Palecek SP. Inductive factors for generation of pluripotent stem cell-derived cardiomyocytes. Engineering Strategies for Regenerative Medicine. Elsevier; 2020. pp. 177-242. [DOI: 10.1016/b978-0-12-816221-7.00006-9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
66 Suuronen EJ, Price J, Veinot JP, Ascah K, Kapila V, Guo X, Wong S, Mesana TG, Ruel M. Comparative effects of mesenchymal progenitor cells, endothelial progenitor cells, or their combination on myocardial infarct regeneration and cardiac function. The Journal of Thoracic and Cardiovascular Surgery 2007;134:1249-58. [DOI: 10.1016/j.jtcvs.2007.07.028] [Cited by in Crossref: 41] [Cited by in F6Publishing: 31] [Article Influence: 2.9] [Reference Citation Analysis]
67 Sommese L, Zullo A, Schiano C, Mancini FP, Napoli C. Possible Muscle Repair in the Human Cardiovascular System. Stem Cell Rev Rep 2017;13:170-91. [PMID: 28058671 DOI: 10.1007/s12015-016-9711-3] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
68 Lowe V, Wisniewski L, Pellet-Many C. The Zebrafish Cardiac Endothelial Cell-Roles in Development and Regeneration. J Cardiovasc Dev Dis 2021;8:49. [PMID: 34062899 DOI: 10.3390/jcdd8050049] [Reference Citation Analysis]
69 Kimura W, Sadek HA. The cardiac hypoxic niche: emerging role of hypoxic microenvironment in cardiac progenitors. Cardiovasc Diagn Ther 2012;2:278-89. [PMID: 24282728 DOI: 10.3978/j.issn.2223-3652.2012.12.02] [Cited by in F6Publishing: 23] [Reference Citation Analysis]
70 Giraud M, Armbruster C, Carrel T, Tevaearai HT. Current State of the Art in Myocardial Tissue Engineering. Tissue Engineering 2007;13:1825-36. [DOI: 10.1089/ten.2006.0110] [Cited by in Crossref: 44] [Cited by in F6Publishing: 36] [Article Influence: 3.1] [Reference Citation Analysis]
71 Menasché P. [Cellular therapy in cardiology]. C R Biol 2007;330:550-6. [PMID: 17631452 DOI: 10.1016/j.crvi.2007.05.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
72 Wang CC, Chen CH, Hwang SM, Lin WW, Huang CH, Lee WY, Chang Y, Sung HW. Spherically symmetric mesenchymal stromal cell bodies inherent with endogenous extracellular matrices for cellular cardiomyoplasty. Stem Cells 2009;27:724-32. [PMID: 19259939 DOI: 10.1634/stemcells.2008-0944] [Cited by in Crossref: 66] [Cited by in F6Publishing: 65] [Article Influence: 5.5] [Reference Citation Analysis]
73 Mahmoud AI, Porrello ER, Kimura W, Olson EN, Sadek HA. Surgical models for cardiac regeneration in neonatal mice. Nat Protoc 2014;9:305-11. [PMID: 24434799 DOI: 10.1038/nprot.2014.021] [Cited by in Crossref: 84] [Cited by in F6Publishing: 75] [Article Influence: 12.0] [Reference Citation Analysis]
74 Luther KM, Haar L, Mcguinness M, Wang Y, Lynch Iv TL, Phan A, Song Y, Shen Z, Gardner G, Kuffel G, Ren X, Zilliox MJ, Jones WK. Exosomal miR-21a-5p mediates cardioprotection by mesenchymal stem cells. Journal of Molecular and Cellular Cardiology 2018;119:125-37. [DOI: 10.1016/j.yjmcc.2018.04.012] [Cited by in Crossref: 72] [Cited by in F6Publishing: 72] [Article Influence: 24.0] [Reference Citation Analysis]
75 Menasché P. Cardiac Cell Therapy Trials: Chronic Myocardial Infarction and Congestive Heart Failure. J of Cardiovasc Trans Res 2008;1:201-6. [DOI: 10.1007/s12265-008-9017-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
76 Giacca M. Cardiac Regeneration After Myocardial Infarction: an Approachable Goal. Curr Cardiol Rep 2020;22:122. [PMID: 32778947 DOI: 10.1007/s11886-020-01361-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
77 Ahuja P, Sdek P, MacLellan WR. Cardiac myocyte cell cycle control in development, disease, and regeneration. Physiol Rev 2007;87:521-44. [PMID: 17429040 DOI: 10.1152/physrev.00032.2006] [Cited by in Crossref: 375] [Cited by in F6Publishing: 319] [Article Influence: 26.8] [Reference Citation Analysis]
78 Wang YL, Yu SN, Shen HR, Wang HJ, Wu XP, Wang QL, Zhou B, Tan YZ. Thymosin β4 released from functionalized self-assembling peptide activates epicardium and enhances repair of infarcted myocardium. Theranostics 2021;11:4262-80. [PMID: 33754060 DOI: 10.7150/thno.52309] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
79 Ting S, Lecina M, Chan YC, Tse HF, Reuveny S, Oh SK. Nutrient supplemented serum-free medium increases cardiomyogenesis efficiency of human pluripotent stem cells. World J Stem Cells 2013;5:86-97. [PMID: 23904910 DOI: 10.4252/wjsc.v5.i3.86] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
80 Khait L, Hecker L, Blan NR, Coyan G, Migneco F, Huang Y, Birla RK. Getting to the Heart of Tissue Engineering. J of Cardiovasc Trans Res 2008;1:71-84. [DOI: 10.1007/s12265-007-9005-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
81 Christoforou N, Gearhart JD. Stem cells and their potential in cell-based cardiac therapies. Prog Cardiovasc Dis 2007;49:396-413. [PMID: 17498520 DOI: 10.1016/j.pcad.2007.02.006] [Cited by in Crossref: 49] [Cited by in F6Publishing: 42] [Article Influence: 3.5] [Reference Citation Analysis]
82 Cao H, Kang BJ, Lee CA, Shung KK, Hsiai TK. Electrical and Mechanical Strategies to Enable Cardiac Repair and Regeneration. IEEE Rev Biomed Eng 2015;8:114-24. [PMID: 25974948 DOI: 10.1109/RBME.2015.2431681] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
83 Menasche P. Cell-based therapy for heart disease: a clinically oriented perspective. Mol Ther 2009;17:758-66. [PMID: 19277020 DOI: 10.1038/mt.2009.40] [Cited by in Crossref: 47] [Cited by in F6Publishing: 34] [Article Influence: 3.9] [Reference Citation Analysis]
84 Leblond AL, O'Sullivan J, Caplice N. Bone marrow mononuclear stem cells: potential in the treatment of myocardial infarction. Stem Cells Cloning 2009;2:11-9. [PMID: 24198506 DOI: 10.2147/sccaa.s6210] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
85 Bengel FM. Noninvasive stem cell tracking. J Nucl Cardiol 2011;18:966-73. [PMID: 21800230 DOI: 10.1007/s12350-011-9436-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
86 Talkhabi M, Pahlavan S, Aghdami N, Baharvand H. Ascorbic acid promotes the direct conversion of mouse fibroblasts into beating cardiomyocytes. Biochem Biophys Res Commun 2015;463:699-705. [PMID: 26047705 DOI: 10.1016/j.bbrc.2015.05.127] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
87 Wang R, Su C, Wang X, Fu Q, Gao X, Zhang C, Yang J, Yang X, Wei M. Global gene expression analysis combined with a genomics approach for the identification of signal transduction networks involved in postnatal mouse myocardial proliferation and development. Int J Mol Med 2018;41:311-21. [PMID: 29115400 DOI: 10.3892/ijmm.2017.3234] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
88 Muller-Borer BJ, Cascio WE, Esch GL, Kim HS, Coleman WB, Grisham JW, Anderson PA, Malouf NN. Mechanisms controlling the acquisition of a cardiac phenotype by liver stem cells. Proc Natl Acad Sci U S A 2007;104:3877-82. [PMID: 17360446 DOI: 10.1073/pnas.0700416104] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
89 Sicari BM, Dearth CL, Badylak SF. Tissue Engineering and Regenerative Medicine Approaches to Enhance the Functional Response to Skeletal Muscle Injury: Tissue Engineering and Regenerative Medicine Approaches to Skeletal Muscle Injury. Anat Rec 2014;297:51-64. [DOI: 10.1002/ar.22794] [Cited by in Crossref: 43] [Cited by in F6Publishing: 33] [Article Influence: 5.4] [Reference Citation Analysis]
90 Marian AJ. Genetic determinants of cardiac hypertrophy. Curr Opin Cardiol. 2008;23:199-205. [PMID: 18382207 DOI: 10.1097/hco.0b013e3282fc27d9] [Cited by in Crossref: 59] [Cited by in F6Publishing: 28] [Article Influence: 4.5] [Reference Citation Analysis]
91 Jonker SS, Zhang L, Louey S, Giraud GD, Thornburg KL, Faber JJ. Myocyte enlargement, differentiation, and proliferation kinetics in the fetal sheep heart. J Appl Physiol (1985) 2007;102:1130-42. [PMID: 17122375 DOI: 10.1152/japplphysiol.00937.2006] [Cited by in Crossref: 103] [Cited by in F6Publishing: 91] [Article Influence: 6.9] [Reference Citation Analysis]
92 Preininger MK, Singh M, Xu C. Cryopreservation of Human Pluripotent Stem Cell-Derived Cardiomyocytes: Strategies, Challenges, and Future Directions. Adv Exp Med Biol 2016;951:123-35. [PMID: 27837559 DOI: 10.1007/978-3-319-45457-3_10] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
93 Jesty SA, Steffey MA, Lee FK, Breitbach M, Hesse M, Reining S, Lee JC, Doran RM, Nikitin AY, Fleischmann BK, Kotlikoff MI. c-kit+ precursors support postinfarction myogenesis in the neonatal, but not adult, heart. Proc Natl Acad Sci U S A 2012;109:13380-5. [PMID: 22847442 DOI: 10.1073/pnas.1208114109] [Cited by in Crossref: 173] [Cited by in F6Publishing: 159] [Article Influence: 19.2] [Reference Citation Analysis]
94 Okura H, Saga A, Soeda M, Miyagawa S, Sawa Y, Daimon T, Ichinose A, Matsuyama A. Intracoronary artery transplantation of cardiomyoblast-like cells from human adipose tissue-derived multi-lineage progenitor cells improve left ventricular dysfunction and survival in a swine model of chronic myocardial infarction. Biochem Biophys Res Commun. 2012;425:859-865. [PMID: 22898045 DOI: 10.1016/j.bbrc.2012.08.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
95 Passier R, van Laake LW, Mummery CL. Stem-cell-based therapy and lessons from the heart. Nature. 2008;453:322-329. [PMID: 18480813 DOI: 10.1038/nature07040] [Cited by in Crossref: 409] [Cited by in F6Publishing: 347] [Article Influence: 31.5] [Reference Citation Analysis]
96 Guan X, Xu W, Zhang H, Wang Q, Yu J, Zhang R, Chen Y, Xia Y, Wang J, Wang D. Transplantation of human induced pluripotent stem cell-derived cardiomyocytes improves myocardial function and reverses ventricular remodeling in infarcted rat hearts. Stem Cell Res Ther 2020;11:73. [PMID: 32085809 DOI: 10.1186/s13287-020-01602-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 13.0] [Reference Citation Analysis]
97 Henning RJ, Aufman J, Shariff M, Sawmiller D, DeLostia V, Sanberg P, Morgan M. Human umbilical cord blood mononuclear cells decrease fibrosis and increase cardiac function in cardiomyopathy. Regen Med 2010;5:45-54. [PMID: 20017693 DOI: 10.2217/rme.09.71] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
98 Guo C, Deng Y, Liu J, Qian L. Cardiomyocyte-specific role of miR-24 in promoting cell survival. J Cell Mol Med 2015;19:103-12. [PMID: 25352422 DOI: 10.1111/jcmm.12393] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
99 Krause K, Schneider C, Kuck K, Jaquet K. REVIEW: Stem Cell Therapy in Cardiovascular Disorders: Stem Cell Therapy in Cardiovascular Disorders. Cardiovascular Therapeutics 2010;28:e101-10. [DOI: 10.1111/j.1755-5922.2010.00208.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
100 Gersh BJ, Simari RD, Behfar A, Terzic CM, Terzic A. Cardiac cell repair therapy: a clinical perspective. Mayo Clin Proc. 2009;84:876-892. [PMID: 19797777 DOI: 10.1016/s0025-6196(11)60505-3] [Cited by in F6Publishing: 45] [Reference Citation Analysis]
101 Nadlacki B, Suuronen EJ. Biomaterial strategies to improve the efficacy of bone marrow cell therapy for myocardial infarction. Expert Opinion on Biological Therapy 2016;16:1501-16. [DOI: 10.1080/14712598.2016.1235149] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
102 Farooq M, Qureshi AS, Squire IB. Early management of ST elevation myocardial infarction: a review of practice. Expert Opinion on Pharmacotherapy 2007;8:401-13. [DOI: 10.1517/14656566.8.4.401] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
103 Raso A, Dirkx E. Cardiac regenerative medicine: At the crossroad of microRNA function and biotechnology. Noncoding RNA Res 2017;2:27-37. [PMID: 30159418 DOI: 10.1016/j.ncrna.2017.03.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
104 Flynn A, O'brien T. Stem cell therapy for cardiac disease. Expert Opinion on Biological Therapy 2011;11:177-87. [DOI: 10.1517/14712598.2011.543894] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
105 Awada HK, Hwang MP, Wang Y. Towards comprehensive cardiac repair and regeneration after myocardial infarction: Aspects to consider and proteins to deliver. Biomaterials 2016;82:94-112. [PMID: 26757257 DOI: 10.1016/j.biomaterials.2015.12.025] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 6.2] [Reference Citation Analysis]
106 Akhmedov AT, Marín-García J. Myocardial regeneration of the failing heart. Heart Fail Rev 2013;18:815-33. [PMID: 23001638 DOI: 10.1007/s10741-012-9348-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
107 Aquila I, Marino F, Cianflone E, Marotta P, Torella M, Mollace V, Indolfi C, Nadal-Ginard B, Torella D. The use and abuse of Cre/Lox recombination to identify adult cardiomyocyte renewal rate and origin. Pharmacol Res 2018;127:116-28. [PMID: 28655642 DOI: 10.1016/j.phrs.2017.06.012] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
108 Sánchez A, García-Sancho J. Cardiac repair by stem cells. Cell Death Differ 2007;14:1258-61. [PMID: 17431420 DOI: 10.1038/sj.cdd.4402146] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
109 Brehm M, Stanske B, Strauer BE. Therapeutic potential of stem cells in elderly patients with cardiovascular disease. Exp Gerontol. 2008;43:1024-1032. [PMID: 18845234 DOI: 10.1016/j.exger.2008.09.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
110 Boffito M, Sartori S, Ciardelli G. Polymeric scaffolds for cardiac tissue engineering: requirements and fabrication technologies: Polymeric scaffolds for cardiac tissue engineering. Polym Int 2014;63:2-11. [DOI: 10.1002/pi.4608] [Cited by in Crossref: 58] [Cited by in F6Publishing: 21] [Article Influence: 7.3] [Reference Citation Analysis]
111 Fernandes S, Kuklok S, McGonigle J, Reinecke H, Murry CE. Synthetic matrices to serve as niches for muscle cell transplantation. Cells Tissues Organs 2012;195:48-59. [PMID: 22005610 DOI: 10.1159/000331414] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
112 Sun W, Zhu J, Li S, Tang C, Zhao Q, Zhang J. Selenium supplementation protects against oxidative stress-induced cardiomyocyte cell cycle arrest through activation of PI3K/AKT. Metallomics 2020;12:1965-78. [PMID: 33237045 DOI: 10.1039/d0mt00225a] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
113 Louey S, Jonker SS, Giraud GD, Thornburg KL. Placental insufficiency decreases cell cycle activity and terminal maturation in fetal sheep cardiomyocytes. J Physiol 2007;580:639-48. [PMID: 17234700 DOI: 10.1113/jphysiol.2006.122200] [Cited by in Crossref: 72] [Cited by in F6Publishing: 67] [Article Influence: 5.1] [Reference Citation Analysis]
114 Rudman J, Frishman WH. Stem Cell Therapy for Acute Myocardial Infarctions: A Systematic Review. Cardiol Rev 2020;28:140-7. [PMID: 32032134 DOI: 10.1097/CRD.0000000000000291] [Reference Citation Analysis]
115 Roura S, Soler-Botija C, Bagó JR, Llucià-Valldeperas A, Férnandez MA, Gálvez-Montón C, Prat-Vidal C, Perea-Gil I, Blanco J, Bayes-Genis A. Postinfarction Functional Recovery Driven by a Three-Dimensional Engineered Fibrin Patch Composed of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells. Stem Cells Transl Med 2015;4:956-66. [PMID: 26106218 DOI: 10.5966/sctm.2014-0259] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 5.7] [Reference Citation Analysis]
116 Drey F, Choi YH, Neef K, Ewert B, Tenbrock A, Treskes P, Bovenschulte H, Liakopoulos OJ, Brenkmann M, Stamm C, Wittwer T, Wahlers T. Noninvasive in vivo tracking of mesenchymal stem cells and evaluation of cell therapeutic effects in a murine model using a clinical 3.0 T MRI. Cell Transplant 2013;22:1971-80. [PMID: 23050950 DOI: 10.3727/096368912X657747] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
117 Kumar R, Sharma A, Pattnaik AK, Varadwaj PK. Stem cells: An overview with respect to cardiovascular and renal disease. J Nat Sci Biol Med. 2010;1:43-52. [PMID: 22096336 DOI: 10.4103/0976-9668.71674] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
118 Rosen MR, Myerburg RJ, Francis DP, Cole GD, Marbán E. Translating stem cell research to cardiac disease therapies: pitfalls and prospects for improvement. J Am Coll Cardiol 2014;64:922-37. [PMID: 25169179 DOI: 10.1016/j.jacc.2014.06.1175] [Cited by in Crossref: 65] [Cited by in F6Publishing: 48] [Article Influence: 9.3] [Reference Citation Analysis]
119 Li ZH, Wang YL, Wang HJ, Wu JH, Tan YZ. Rapamycin-Preactivated Autophagy Enhances Survival and Differentiation of Mesenchymal Stem Cells After Transplantation into Infarcted Myocardium. Stem Cell Rev Rep 2020;16:344-56. [PMID: 31927699 DOI: 10.1007/s12015-020-09952-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
120 Chen CH, Sereti KI, Wu BM, Ardehali R. Translational aspects of cardiac cell therapy. J Cell Mol Med 2015;19:1757-72. [PMID: 26119413 DOI: 10.1111/jcmm.12632] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
121 Beliën H, Evens L, Hendrikx M, Bito V, Bronckaers A. Combining stem cells in myocardial infarction: The road to superior repair? Med Res Rev 2021. [PMID: 34114238 DOI: 10.1002/med.21839] [Reference Citation Analysis]
122 Lutz M, Rosenberg M, Kiessling F, Eckstein V, Heger T, Krebs J, Ho AD, Katus HA, Frey N. Local injection of stem cell factor (SCF) improves myocardial homing of systemically delivered c-kit + bone marrow-derived stem cells. Cardiovascular Research 2008;77:143-50. [DOI: 10.1093/cvr/cvm027] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 2.6] [Reference Citation Analysis]
123 Hayashi Y, Horiguchi I, Kino-oka M, Sugiyama H. Slow freezing process design for human induced pluripotent stem cells by modeling intracontainer variation. Computers & Chemical Engineering 2020;132:106597. [DOI: 10.1016/j.compchemeng.2019.106597] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 7.0] [Reference Citation Analysis]
124 McEwan K, Padavan DT, Deng C, Vulesevic B, Kuraitis D, Korbutt GS, Suuronen EJ. Tunable collagen hydrogels are modified by the therapeutic agents they are designed to deliver. J Biomater Sci Polym Ed 2012;23:1467-83. [PMID: 21771391 DOI: 10.1163/092050611X584397] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
125 Wang Y, Qian DJ, Zhong WY, Lu JH, Guo XK, Cao YL, Liu J. TGF-β1 induces the formation of vascular-like structures in embryoid bodies derived from human embryonic stem cells. Exp Ther Med 2014;8:52-8. [PMID: 24944596 DOI: 10.3892/etm.2014.1721] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
126 Lisi A, Briganti E, Ledda M, Losi P, Grimaldi S, Marchese R, Soldani G. A combined synthetic-fibrin scaffold supports growth and cardiomyogenic commitment of human placental derived stem cells. PLoS One. 2012;7:e34284. [PMID: 22509287 DOI: 10.1371/journal.pone.0034284] [Cited by in Crossref: 31] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
127 Allan R, Kass M, Glover C, Haddad H. Cellular transplantation: future therapeutic options. Current Opinion in Cardiology 2007;22:104-10. [DOI: 10.1097/hco.0b013e3280210657] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
128 Tanaka EM, Weidinger G. Micromanaging regeneration. Genes Dev 2008;22:700-5. [PMID: 18347087 DOI: 10.1101/gad.1660508] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
129 Ebert SN, Taylor DG, Nguyen HL, Kodack DP, Beyers RJ, Xu Y, Yang Z, French BA. Noninvasive tracking of cardiac embryonic stem cells in vivo using magnetic resonance imaging techniques. Stem Cells 2007;25:2936-44. [PMID: 17690182 DOI: 10.1634/stemcells.2007-0216] [Cited by in Crossref: 61] [Cited by in F6Publishing: 54] [Article Influence: 4.4] [Reference Citation Analysis]
130 Tian S, Liu Q, Gnatovskiy L, Ma PX, Wang Z. Heart Regeneration with Embryonic Cardiac Progenitor Cells and Cardiac Tissue Engineering. J Stem Cell Transplant Biol 2015;1:104. [PMID: 26744736 DOI: 10.19104/jstb.2015.104] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
131 Okura H, Matsuyama A, Lee CM, Saga A, Kakuta-Yamamoto A, Nagao A, Sougawa N, Sekiya N, Takekita K, Shudo Y. Cardiomyoblast-like cells differentiated from human adipose tissue-derived mesenchymal stem cells improve left ventricular dysfunction and survival in a rat myocardial infarction model. Tissue Eng Part C Methods. 2010;16:417-425. [PMID: 19624256 DOI: 10.1089/ten.tec.2009.0362] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 4.3] [Reference Citation Analysis]
132 Schuldt AJ, Rosen MR, Gaudette GR, Cohen IS. Repairing damaged myocardium: evaluating cells used for cardiac regeneration. Curr Treat Options Cardiovasc Med 2008;10:59-72. [PMID: 18325308 DOI: 10.1007/s11936-008-0007-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
133 Kristen M, Ainsworth MJ, Chirico N, van der Ven CFT, Doevendans PA, Sluijter JPG, Malda J, van Mil A, Castilho M. Fiber Scaffold Patterning for Mending Hearts: 3D Organization Bringing the Next Step. Adv Healthc Mater 2020;9:e1900775. [PMID: 31603288 DOI: 10.1002/adhm.201900775] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
134 Sargent CY, Berguig GY, Mcdevitt TC. Cardiomyogenic Differentiation of Embryoid Bodies Is Promoted by Rotary Orbital Suspension Culture. Tissue Engineering Part A 2009;15:331-42. [DOI: 10.1089/ten.tea.2008.0145] [Cited by in Crossref: 51] [Cited by in F6Publishing: 42] [Article Influence: 4.3] [Reference Citation Analysis]
135 Chen CH, Wei HJ, Lin WW, Chiu I, Hwang SM, Wang CC, Lee WY, Chang Y, Sung HW. Porous tissue grafts sandwiched with multilayered mesenchymal stromal cell sheets induce tissue regeneration for cardiac repair. Cardiovasc Res 2008;80:88-95. [PMID: 18539631 DOI: 10.1093/cvr/cvn149] [Cited by in Crossref: 44] [Cited by in F6Publishing: 32] [Article Influence: 3.4] [Reference Citation Analysis]
136 Gamba L, Harrison M, Lien CL. Cardiac regeneration in model organisms. Curr Treat Options Cardiovasc Med 2014;16:288. [PMID: 24496965 DOI: 10.1007/s11936-013-0288-8] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 4.1] [Reference Citation Analysis]
137 Cargnoni A, Di Marcello M, Campagnol M, Nassuato C, Albertini A, Parolini O. Amniotic membrane patching promotes ischemic rat heart repair. Cell Transplant. 2009;18:1147-1159. [PMID: 19650976 DOI: 10.3727/096368909x12483162196764] [Cited by in Crossref: 65] [Cited by in F6Publishing: 26] [Article Influence: 5.4] [Reference Citation Analysis]
138 Nunes SS, Song H, Chiang CK, Radisic M. Stem Cell-Based Cardiac Tissue Engineering. J of Cardiovasc Trans Res 2011;4:592-602. [DOI: 10.1007/s12265-011-9307-x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 3.5] [Reference Citation Analysis]
139 Tuyn J, Pijnappels DA, Vries AAF, Vries I, Velde‐van Dijke I, Knaän‐shanzer S, Laarse A, Schalij MJ, Atsma DE. Fibroblasts from human postmyocardial infarction scars acquire properties of cardiomyocytes after transduction with a recombinant myocardin gene. FASEB j 2007;21:3369-79. [DOI: 10.1096/fj.07-8211com] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
140 Binah O, Dolnikov K, Sadan O, Shilkrut M, Zeevi-Levin N, Amit M, Danon A, Itskovitz-Eldor J. Functional and developmental properties of human embryonic stem cells-derived cardiomyocytes. J Electrocardiol 2007;40:S192-6. [PMID: 17993321 DOI: 10.1016/j.jelectrocard.2007.05.035] [Cited by in Crossref: 59] [Cited by in F6Publishing: 53] [Article Influence: 4.5] [Reference Citation Analysis]
141 Dengler J, Radisic M. Tissue engineering approaches for the development of a contractile cardiac patch. Future Cardiol 2007;3:425-34. [PMID: 19804233 DOI: 10.2217/14796678.3.4.425] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
142 Karra R, Wu SM. Multipotent stem cells in cardiac regenerative therapy. Regen Med 2008;3:189-98. [PMID: 18307403 DOI: 10.2217/17460751.3.2.189] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
143 Carr CA, Stuckey DJ, Tatton L, Tyler DJ, Hale SJ, Sweeney D, Schneider JE, Martin-Rendon E, Radda GK, Harding SE, Watt SM, Clarke K. Bone marrow-derived stromal cells home to and remain in the infarcted rat heart but fail to improve function: an in vivo cine-MRI study. Am J Physiol Heart Circ Physiol 2008;295:H533-42. [PMID: 18539761 DOI: 10.1152/ajpheart.00094.2008] [Cited by in Crossref: 62] [Cited by in F6Publishing: 59] [Article Influence: 4.8] [Reference Citation Analysis]
144 Karabekian Z, Posnack NG, Sarvazyan N. Immunological barriers to stem-cell based cardiac repair. Stem Cell Rev Rep 2011;7:315-25. [PMID: 21086071 DOI: 10.1007/s12015-010-9202-x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 2.2] [Reference Citation Analysis]
145 Sicari BM, Dziki JL, Badylak SF. Strategies for functional bioscaffold-based skeletal muscle reconstruction. Ann Transl Med 2015;3:256. [PMID: 26605302 DOI: 10.3978/j.issn.2305-5839.2015.09.45] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
146 Sturzu AC, Wu SM. Developmental and regenerative biology of multipotent cardiovascular progenitor cells. Circ Res 2011;108:353-64. [PMID: 21293007 DOI: 10.1161/CIRCRESAHA.110.227066] [Cited by in Crossref: 60] [Cited by in F6Publishing: 34] [Article Influence: 6.0] [Reference Citation Analysis]
147 Morez C, Noseda M, Paiva MA, Belian E, Schneider MD, Stevens MM. Enhanced efficiency of genetic programming toward cardiomyocyte creation through topographical cues. Biomaterials 2015;70:94-104. [PMID: 26302234 DOI: 10.1016/j.biomaterials.2015.07.063] [Cited by in Crossref: 58] [Cited by in F6Publishing: 54] [Article Influence: 9.7] [Reference Citation Analysis]
148 Rheault-Henry M, White I, Grover D, Atoui R. Stem cell therapy for heart failure: Medical breakthrough, or dead end? World J Stem Cells 2021;13:236-59. [PMID: 33959217 DOI: 10.4252/wjsc.v13.i4.236] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
149 Maldonado-Velez G, Firulli AB. Mechanisms Underlying Cardiomyocyte Development: Can We Exploit Them to Regenerate the Heart? Curr Cardiol Rep 2021;23:81. [PMID: 34081213 DOI: 10.1007/s11886-021-01510-6] [Reference Citation Analysis]
150 Huntington J, Pachauri M, Ali H, Giacca M. RNA interference therapeutics for cardiac regeneration. Curr Opin Genet Dev 2021;70:48-53. [PMID: 34098251 DOI: 10.1016/j.gde.2021.05.007] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
151 Menasché P. Skeletal myoblasts and cardiac repair. Journal of Molecular and Cellular Cardiology 2008;45:545-53. [DOI: 10.1016/j.yjmcc.2007.11.009] [Cited by in Crossref: 56] [Cited by in F6Publishing: 48] [Article Influence: 4.3] [Reference Citation Analysis]
152 Suuronen EJ, Hazra S, Zhang P, Vincent R, Kumarathasan P, Zhang Y, Price J, Chan V, Sellke FW, Mesana TG, Veinot JP, Ruel M. Impairment of human cell-based vasculogenesis in rats by hypercholesterolemia-induced endothelial dysfunction and rescue with L-arginine supplementation. J Thorac Cardiovasc Surg 2010;139:209-216.e2. [PMID: 20106366 DOI: 10.1016/j.jtcvs.2009.04.055] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
153 Gharaibeh B, Chun-Lansinger Y, Hagen T, Ingham SJ, Wright V, Fu F, Huard J. Biological approaches to improve skeletal muscle healing after injury and disease. Birth Defects Res C Embryo Today 2012;96:82-94. [PMID: 22457179 DOI: 10.1002/bdrc.21005] [Cited by in Crossref: 70] [Cited by in F6Publishing: 54] [Article Influence: 7.8] [Reference Citation Analysis]
154 Zweigerdt R. Large scale production of stem cells and their derivatives. Adv Biochem Eng Biotechnol 2009;114:201-35. [PMID: 19513633 DOI: 10.1007/10_2008_27] [Cited by in Crossref: 12] [Cited by in F6Publishing: 29] [Article Influence: 1.7] [Reference Citation Analysis]
155 Ho YT, Poinard B, Kah JCY. Nanoparticle drug delivery systems and their use in cardiac tissue therapy. Nanomedicine 2016;11:693-714. [DOI: 10.2217/nnm.16.6] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 4.2] [Reference Citation Analysis]
156 Davidson SM, Arjun S, Basalay MV, Bell RM, Bromage DI, Bøtker HE, Carr RD, Cunningham J, Ghosh AK, Heusch G, Ibanez B, Kleinbongard P, Lecour S, Maddock H, Ovize M, Walker M, Wiart M, Yellon DM. The 10th Biennial Hatter Cardiovascular Institute workshop: cellular protection-evaluating new directions in the setting of myocardial infarction, ischaemic stroke, and cardio-oncology. Basic Res Cardiol 2018;113:43. [PMID: 30310998 DOI: 10.1007/s00395-018-0704-z] [Cited by in Crossref: 59] [Cited by in F6Publishing: 53] [Article Influence: 19.7] [Reference Citation Analysis]
157 Lee RJ. Stem cells for myocardial repair and regeneration: where are we today? Methods Mol Biol 2010;660:1-6. [PMID: 20680809 DOI: 10.1007/978-1-60761-705-1_1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
158 Correia C, Serra M, Espinha N, Sousa M, Brito C, Burkert K, Zheng Y, Hescheler J, Carrondo MJ, Sarić T, Alves PM. Combining hypoxia and bioreactor hydrodynamics boosts induced pluripotent stem cell differentiation towards cardiomyocytes. Stem Cell Rev Rep 2014;10:786-801. [PMID: 25022569 DOI: 10.1007/s12015-014-9533-0] [Cited by in Crossref: 47] [Cited by in F6Publishing: 34] [Article Influence: 7.8] [Reference Citation Analysis]
159 Coulombe KL, Bajpai VK, Andreadis ST, Murry CE. Heart regeneration with engineered myocardial tissue. Annu Rev Biomed Eng 2014;16:1-28. [PMID: 24819474 DOI: 10.1146/annurev-bioeng-071812-152344] [Cited by in Crossref: 53] [Cited by in F6Publishing: 45] [Article Influence: 7.6] [Reference Citation Analysis]
160 Addis RC, Epstein JA. Induced regeneration--the progress and promise of direct reprogramming for heart repair. Nat Med. 2013;19:829-836. [PMID: 23836233 DOI: 10.1038/nm.3225] [Cited by in Crossref: 71] [Cited by in F6Publishing: 54] [Article Influence: 8.9] [Reference Citation Analysis]
161 Budniatzky I, Gepstein L. Concise review: reprogramming strategies for cardiovascular regenerative medicine: from induced pluripotent stem cells to direct reprogramming. Stem Cells Transl Med. 2014;3:448-457. [PMID: 24591731 DOI: 10.5966/sctm.2013-0163] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
162 Matsuda K, Falkenberg KJ, Woods AA, Choi YS, Morrison WA, Dilley RJ. Adipose-derived stem cells promote angiogenesis and tissue formation for in vivo tissue engineering. Tissue Eng Part A. 2013;19:1327-1335. [PMID: 23394225 DOI: 10.1089/ten.tea.2012.0391] [Cited by in Crossref: 72] [Cited by in F6Publishing: 58] [Article Influence: 9.0] [Reference Citation Analysis]
163 Beitnes JO, Lunde K, Brinchmann JE, Aakhus S. Stem cells for cardiac repair in acute myocardial infarction. Expert Rev Cardiovasc Ther 2011;9:1015-25. [PMID: 21878046 DOI: 10.1586/erc.11.108] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
164 Cannatà A, Ali H, Sinagra G, Giacca M. Gene Therapy for the Heart Lessons Learned and Future Perspectives. Circ Res 2020;126:1394-414. [PMID: 32379579 DOI: 10.1161/CIRCRESAHA.120.315855] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 18.0] [Reference Citation Analysis]
165 Braga L, Ali H, Secco I, Giacca M. Non-coding RNA therapeutics for cardiac regeneration. Cardiovasc Res 2021;117:674-93. [PMID: 32215566 DOI: 10.1093/cvr/cvaa071] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 16.0] [Reference Citation Analysis]
166 Terrovitis J, Lautamäki R, Bonios M, Fox J, Engles JM, Yu J, Leppo MK, Pomper MG, Wahl RL, Seidel J, Tsui BM, Bengel FM, Abraham MR, Marbán E. Noninvasive quantification and optimization of acute cell retention by in vivo positron emission tomography after intramyocardial cardiac-derived stem cell delivery. J Am Coll Cardiol 2009;54:1619-26. [PMID: 19833262 DOI: 10.1016/j.jacc.2009.04.097] [Cited by in Crossref: 198] [Cited by in F6Publishing: 168] [Article Influence: 16.5] [Reference Citation Analysis]
167 Shijun X, Junsheng M, Jianqun Z, Ping B. In vitro three-dimensional coculturing poly3-hydroxybutyrate- co -3-hydroxyhexanoate with mouse-induced pluripotent stem cells for myocardial patch application. J Biomater Appl 2016;30:1273-82. [DOI: 10.1177/0885328215612115] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
168 Suuronen EJ, Zhang P, Kuraitis D, Cao X, Melhuish A, McKee D, Li F, Mesana TG, Veinot JP, Ruel M. An acellular matrix-bound ligand enhances the mobilization, recruitment and therapeutic effects of circulating progenitor cells in a hindlimb ischemia model. FASEB J 2009;23:1447-58. [PMID: 19136616 DOI: 10.1096/fj.08-111054] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 3.0] [Reference Citation Analysis]
169 Davis DR, Stewart DJ. Autologous cell therapy for cardiac repair. Expert Opinion on Biological Therapy 2011;11:489-508. [DOI: 10.1517/14712598.2011.556615] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
170 Christoforou N, Chellappan M, Adler AF, Kirkton RD, Wu T, Addis RC, Bursac N, Leong KW. Transcription factors MYOCD, SRF, Mesp1 and SMARCD3 enhance the cardio-inducing effect of GATA4, TBX5, and MEF2C during direct cellular reprogramming. PLoS One 2013;8:e63577. [PMID: 23704920 DOI: 10.1371/journal.pone.0063577] [Cited by in Crossref: 99] [Cited by in F6Publishing: 84] [Article Influence: 12.4] [Reference Citation Analysis]
171 Menasché P. Current status and future prospects for cell transplantation to prevent congestive heart failure. Semin Thorac Cardiovasc Surg 2008;20:131-7. [PMID: 18707646 DOI: 10.1053/j.semtcvs.2008.03.001] [Cited by in Crossref: 39] [Cited by in F6Publishing: 31] [Article Influence: 3.0] [Reference Citation Analysis]
172 Potapova IA, Doronin SV, Kelly DJ, Rosen AB, Schuldt AJ, Lu Z, Kochupura PV, Robinson RB, Rosen MR, Brink PR. Enhanced recovery of mechanical function in the canine heart by seeding an extracellular matrix patch with mesenchymal stem cells committed to a cardiac lineage. Am J Physiol Heart Circ Physiol. 2008;295:H2257-H2263. [PMID: 18835924 DOI: 10.1152/ajpheart.00219.2008] [Cited by in Crossref: 48] [Cited by in F6Publishing: 37] [Article Influence: 3.7] [Reference Citation Analysis]
173 Chen HS, Kim C, Mercola M. Electrophysiological challenges of cell-based myocardial repair. Circulation. 2009;120:2496-2508. [PMID: 20008740 DOI: 10.1161/circulationaha.107.751412] [Cited by in Crossref: 82] [Cited by in F6Publishing: 45] [Article Influence: 7.5] [Reference Citation Analysis]
174 Ryan R, Moyse BR, Richardson RJ. Zebrafish cardiac regeneration-looking beyond cardiomyocytes to a complex microenvironment. Histochem Cell Biol 2020;154:533-48. [PMID: 32926230 DOI: 10.1007/s00418-020-01913-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
175 Chow A, Stuckey DJ, Kidher E, Rocco M, Jabbour RJ, Mansfield CA, Darzi A, Harding SE, Stevens MM, Athanasiou T. Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Encapsulating Bioactive Hydrogels Improve Rat Heart Function Post Myocardial Infarction. Stem Cell Reports. 2017;9:1415-1422. [PMID: 28988988 DOI: 10.1016/j.stemcr.2017.09.003] [Cited by in Crossref: 55] [Cited by in F6Publishing: 46] [Article Influence: 13.8] [Reference Citation Analysis]
176 Kempf H, Lecina M, Ting S, Zweigerdt R, Oh S. Distinct regulation of mitogen-activated protein kinase activities is coupled with enhanced cardiac differentiation of human embryonic stem cells. Stem Cell Res. 2011;7:198-209. [PMID: 21907163 DOI: 10.1016/j.scr.2011.06.001] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
177 Beffagna G. Zebrafish as a Smart Model to Understand Regeneration After Heart Injury: How Fish Could Help Humans. Front Cardiovasc Med 2019;6:107. [PMID: 31448289 DOI: 10.3389/fcvm.2019.00107] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
178 Van't Hof W, Mal N, Huang Y, Zhang M, Popovic Z, Forudi F, Deans R, Penn MS. Direct delivery of syngeneic and allogeneic large-scale expanded multipotent adult progenitor cells improves cardiac function after myocardial infarct. Cytotherapy 2007;9:477-87. [PMID: 17786609 DOI: 10.1080/14653240701452065] [Cited by in Crossref: 50] [Cited by in F6Publishing: 38] [Article Influence: 3.6] [Reference Citation Analysis]
179 Tang Y, Zhao L, Yu X, Zhang J, Qian L, Jin J, Lu R, Zhou Y. Inhibition of EZH2 primes the cardiac gene activation via removal of epigenetic repression during human direct cardiac reprogramming. Stem Cell Res 2021;53:102365. [PMID: 34087994 DOI: 10.1016/j.scr.2021.102365] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
180 Lecina M, Ting S, Choo A, Reuveny S, Oh S. Scalable platform for human embryonic stem cell differentiation to cardiomyocytes in suspended microcarrier cultures. Tissue Eng Part C Methods. 2010;16:1609-1619. [PMID: 20590381 DOI: 10.1089/ten.tec.2010.0104] [Cited by in Crossref: 98] [Cited by in F6Publishing: 78] [Article Influence: 8.9] [Reference Citation Analysis]
181 Ashton RS, Keung AJ, Peltier J, Schaffer DV. Progress and prospects for stem cell engineering. Annu Rev Chem Biomol Eng 2011;2:479-502. [PMID: 22432628 DOI: 10.1146/annurev-chembioeng-061010-114105] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
182 Menasché P. Skeletal myoblasts for cardiac repair: Act II? J Am Coll Cardiol 2008;52:1881-3. [PMID: 19038686 DOI: 10.1016/j.jacc.2008.07.066] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
183 Yeong WY, Yu H, Lim KP, Ng KLG, Boey YCF, Subbu VS, Tan LP. Multiscale Topological Guidance for Cell Alignment via Direct Laser Writing on Biodegradable Polymer. Tissue Engineering Part C: Methods 2010;16:1011-21. [DOI: 10.1089/ten.tec.2009.0604] [Cited by in Crossref: 54] [Cited by in F6Publishing: 34] [Article Influence: 4.9] [Reference Citation Analysis]
184 Zheng L, Du J, Wang Z, Zhou Q, Zhu X, Xiong JW. Molecular regulation of myocardial proliferation and regeneration. Cell Regen 2021;10:13. [PMID: 33821373 DOI: 10.1186/s13619-021-00075-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
185 Zweigerdt R. The art of cobbling a running pump--will human embryonic stem cells mend broken hearts? Semin Cell Dev Biol. 2007;18:794-804. [PMID: 18006339 DOI: 10.1016/j.semcdb.2007.09.014] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
186 Stevens KR, Pabon L, Muskheli V, Murry CE. Scaffold-free human cardiac tissue patch created from embryonic stem cells. Tissue Eng Part A 2009;15:1211-22. [PMID: 19063661 DOI: 10.1089/ten.tea.2008.0151] [Cited by in Crossref: 126] [Cited by in F6Publishing: 92] [Article Influence: 10.5] [Reference Citation Analysis]
187 Guddati AK, Otero JJ, Kessler E, Aistrup G, Wasserstrom JA, Han X, Lomasney JW, Kessler JA. Embryonic stem cells overexpressing Pitx2c engraft in infarcted myocardium and improve cardiac function. Int Heart J 2009;50:783-99. [PMID: 19952475 DOI: 10.1536/ihj.50.783] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
188 van Amerongen MJ, Engel FB. Features of cardiomyocyte proliferation and its potential for cardiac regeneration. J Cell Mol Med 2008;12:2233-44. [PMID: 18662194 DOI: 10.1111/j.1582-4934.2008.00439.x] [Cited by in Crossref: 83] [Cited by in F6Publishing: 74] [Article Influence: 6.4] [Reference Citation Analysis]
189 Gulati R, Simari RD. Cell therapy for acute myocardial infarction. Med Clin North Am 2007;91:769-85; xiii. [PMID: 17640547 DOI: 10.1016/j.mcna.2007.03.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
190 Hamdi H, Furuta A, Bellamy V, Bel A, Puymirat E, Peyrard S, Agbulut O, Menasché P. Cell delivery: intramyocardial injections or epicardial deposition? A head-to-head comparison. Ann Thorac Surg 2009;87:1196-203. [PMID: 19324150 DOI: 10.1016/j.athoracsur.2008.12.074] [Cited by in Crossref: 99] [Cited by in F6Publishing: 75] [Article Influence: 8.3] [Reference Citation Analysis]
191 Xiang FL, Lu X, Hammoud L, Zhu P, Chidiac P, Robbins J, Feng Q. Cardiomyocyte-specific overexpression of human stem cell factor improves cardiac function and survival after myocardial infarction in mice. Circulation 2009;120:1065-74, 9 p following 1074. [PMID: 19738140 DOI: 10.1161/CIRCULATIONAHA.108.839068] [Cited by in Crossref: 41] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
192 Yan C, Xu Z, Huang W. Cellular Senescence Affects Cardiac Regeneration and Repair in Ischemic Heart Disease. Aging Dis 2021;12:552-69. [PMID: 33815882 DOI: 10.14336/AD.2020.0811] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
193 Gharaibeh B, Lavasani M, Cummins JH, Huard J. Terminal differentiation is not a major determinant for the success of stem cell therapy - cross-talk between muscle-derived stem cells and host cells. Stem Cell Res Ther 2011;2:31. [PMID: 21745421 DOI: 10.1186/scrt72] [Cited by in Crossref: 53] [Cited by in F6Publishing: 43] [Article Influence: 5.3] [Reference Citation Analysis]